Page: 1 of 30 1 2 3 4 5

Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany Channel: www.ecancer.tv Length: 0 Date: March 01, 2011 Prof Mathias Rummel discusses his research demonstrating the efficacy of bendamustine plus rituximab as a treatment for mantle cell lymphomas (MCL)...

Chair: Prof Meletios Dimopoulos - Univeristy of Athens, Greece; Prof Hermann Einsele - Medizinische Klinik II, Wurzburg, Germany; Prof Mario Boccadoro - University of Turin, Italy; Dr Maria-Victoria Channel: www.ecancer.tv Length: 0 Date: March 01, 2011 The panel discuss how the results of recent clinical trials have advanced our understanding of the optimal treatment for multiple myeloma. The deve...

Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany Channel: www.ecancer.tv Length: 0 Date: March 01, 2011 Prof Mathias Rummel talks about the history of bendamustine from its origins in 1960’s East Germany to the modern trials evaluating the use of bend...

Prof Antonio Palumbo - Molinette Hospital, Turin, Italy and Prof Vincent Rajkumar - Mayo Clinic, Arizona, USA Channel: www.ecancer.tv Length: 0 Date: March 01, 2011 Prof Antonio Palumbo and Prof Vincent Rajkumar discuss some of the key research into myeloma that was presented at ASH 2010. This includes trials d...

Prof Anton Hagenbeek - Academic Medical Center, Amsterdam, Netherlands Channel: www.ecancer.tv Length: 0 Date: February 23, 2011 Prof Anton Hagenbeek discusses the five and a half year results of the First-Line Indolent Trial (FIT) study. The randomised phase III FIT study ev...

Prof Valeria Santini - University of Florence, Italy Channel: www.ecancer.tv Length: 0 Date: February 21, 2011 Prof Valeria Santini talks about the results of her research on the use of comorbidity indexes to determine prognosis for elderly myelodysplastic s...

Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network Channel: www.ecancer.tv Length: 0 Date: February 21, 2011 The groundbreaking introduction of the tyrosine kinase inhibitor (TKI) imatinib as a treatment for chronic myeloid leukaemia (CML) has been followe...

Prof George Canellos - Harvard Medical School, Boston, USA Channel: www.ecancer.tv Length: 0 Date: February 21, 2011 Prof George Canellos talks about the key research that has emerged from the 2010 ASH meeting in Florida. One trial of note compared the Stanford V ...

Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Prof Timothy Hughes speaks to ecancer.tv about the ENESTnd trial which is evaluating the efficacy and safety of the second generation tyrosine kina...

Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Dr Reinhard Stauder speaks about his aims for the upcoming ecancer meeting on haematological cancers in elderly patients, Rome, 18-20th March 2011...

Dr Michael Keating- MD Anderson Cancer Center, Texas, USA Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Dr Michael Keating discusses his pick of the research presented at ASH 2010. This includes trials looking at new tyrosine kinase inhibitors that ta...

Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Prof Kanti Rai discusses advances that have been made in the treatment of chronic lymphocytic leukaemia (CLL). Key research presented at this years...

Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Prof Pieter Sonneveld speaks about a trial evaluating the efficacy of bortezomib during induction and maintenance therapy on progression-free survi...

Prof Wyndham Wilson - National Cancer Institute, Maryland, USA Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Prof Wyndham Wilson provides a comprehensive summary of the key lymphoma related research presented at the 2010 ASH congress in Florida. The first ...

Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Dr William Matsui speaks about plasma cell biology and how this affects cancer growth. In multiple myeloma, malignant plasma cells make up the vas...

Jan Geissler - Co-Founder, CML Advocates Network Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Jan Geissler speaks about some of the key research into chronic myeloid leukaemia (CML) that has been presented at ASH 2010. This includes papers o...

Jan Geissler - Co-Founder, CML Advocates Network Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Jan Geissler speaks about the upcoming ecancer meeting on haematological cancers in the elderly which will be held in Rome, 18-20th March 2011. Th...

Dr Jerald Radich - Fred Hutchinson Cancer Research Center, Seattle, USA Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Dr Jerald Radich speaks about the treatment options that are available for chronic myeloid leukaemia (CML). Tyrosine kinase inhibitors such as imat...

Prof Stephen Baylin - Johns Hopkins University, Maryland, USA Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Prof Stephen Baylin speaks to ecancertv about epigenetics. He explains what epigenetics is, how it is being used to treat cancer and how it may po...

Prof Giuseppe Saglio - University of Turin, Italy Channel: www.ecancer.tv Length: 0 Date: February 18, 2011 Prof Giuseppe Saglio speaks about the DASISION trial which compares dasatinib with imatinib as initial treatment for patients with newly diagnosed ...

Page: 1 of 30 1 2 3 4 5